These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16777495)

  • 21. A Case of Phage Therapy against Pandrug-Resistant
    Lebeaux D; Merabishvili M; Caudron E; Lannoy D; Van Simaey L; Duyvejonck H; Guillemain R; Thumerelle C; Podglajen I; Compain F; Kassis N; Mainardi JL; Wittmann J; Rohde C; Pirnay JP; Dufour N; Vermeulen S; Gansemans Y; Van Nieuwerburgh F; Vaneechoutte M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
    Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.
    De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S
    Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
    Wellinghausen N; Wirths B; Poppert S
    J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis.
    Aanaes K; von Buchwald C; Hjuler T; Skov M; Alanin M; Johansen HK
    Am J Rhinol Allergy; 2013 Jan; 27(1):e1-4. PubMed ID: 23406585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the
    Le Goff M; Vastel M; Lebrun R; Mansuelle P; Diarra A; Grandjean T; Triponney P; Imbert G; Gosset P; Dessein R; Garnier F; Durand E
    Front Cell Infect Microbiol; 2022; 12():859181. PubMed ID: 35782124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW; Nguyen CD; Foster JM; Burns JL
    J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
    Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
    J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis.
    Recio R; Brañas P; Martínez MT; Chaves F; Orellana MA
    J Med Microbiol; 2018 Jul; 67(7):952-956. PubMed ID: 29787364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease.
    Stobbelaar K; Van Hoorenbeeck K; Lequesne M; De Dooy J; Ho E; Vlieghe E; Ieven M; Verhulst S
    Am J Case Rep; 2016 Aug; 17():562-6. PubMed ID: 27498677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.
    Pereira RH; Carvalho-Assef AP; Albano RM; Folescu TW; Jones MC; Leão RS; Marques EA
    J Clin Microbiol; 2011 Oct; 49(10):3649-51. PubMed ID: 21849686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose intolerance in patients with cystic fibrosis: sex-based differences in clinical score, pulmonary function, radiograph score, and 6-minute walk test.
    Ziegler B; Oliveira CL; Rovedder PM; Schuh SJ; Abreu E Silva FA; Dalcin Pde T
    Respir Care; 2011 Mar; 56(3):290-7. PubMed ID: 21255491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact.
    Hansen CR; Pressler T; Ridderberg W; Johansen HK; Skov M
    J Cyst Fibros; 2013 Dec; 12(6):609-15. PubMed ID: 23769270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe.
    Adam P; Czapiewski P; Colak S; Kosmidis P; Tousseyn T; Sagaert X; Boudova L; Okoń K; Morresi-Hauf A; Agostinelli C; Pileri S; Pruneri G; Martinelli G; Du MQ; Fend F
    Br J Haematol; 2014 Mar; 164(6):804-10. PubMed ID: 24372375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing.
    Liu C; Guo J; Yan W; Jin Y; Pan F; Fang X; Qin L; Liu C
    J Infect Dev Ctries; 2017 Jan; 11(1):10-18. PubMed ID: 28141585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging and unusual gram-negative infections in cystic fibrosis.
    Davies JC; Rubin BK
    Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The
    Pickrum AM; Riegert MO; Wells C; Brockman K; Frank DW
    Microbiol Spectr; 2022 Aug; 10(4):e0208322. PubMed ID: 35856670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.